MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
University Hospital Heidelberg
Heidelberg, AlemaniaUniversity Hospital Heidelberg-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2021
-
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491
2018
2016
-
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study
The Lancet, Vol. 387, Núm. 10020, pp. 770-778